Ethynyl derivatives

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12006323
SERIAL NO

17315349

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HOFFMANN-LA ROCHE, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Biemans, Barbara Riehen, CH 13 41
Guba, Wolfgang Muellheim, DE 70 314
Jaeschke, Georg Basel, CH 113 403
Lindemann, Lothar Basel, CH 36 73
O'Hara, Fionn Basel, CH 27 88
Ricci, Antonio Biel-Benken, CH 78 220
Rueher, Daniel Raedersdorf, FR 43 101
Vieira, Eric Frenkendorf, CH 81 783

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 11, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 11, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 11, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00